Announcements Trials
Browse Landscape

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 2Breast 2Tumor-Agnostic 1Sarcoma 1NET 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Speech 1

Interventions

Cisplatin 57pembrolizumab 54Cetuximab 43Radiotherapy 35Docetaxel 21Radiotherapy, Intensity-Modulated 20Paclitaxel 19Nivolumab 18Fluorouracil 18Carboplatin 17Radiation 14Radiosurgery 9Magnetic Resonance Spectroscopy 8Gemcitabine 8Everolimus 8Biopsy 8Surgical Procedures, Operative 7Oxaliplatin 7Cyclophosphamide 7durvalumab 6avelumab 6Erlotinib Hydrochloride 6Capecitabine 6spartalizumab 5epacadostat 5Surveys and Questionnaires 5Platinum 5Immunoglobulin G 5Gefitinib 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Quality of Life × Head & Neck × Clear all
NCT02552550 2018-06-04

Swallowing, Speech and Quality of Life of Patients With Carcinoma of the Oropharynx

Centre Hospitalier Universitaire de Saint Etienne

Terminated
12 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Speech

Data powered by HemOnc (CC BY 4.0) Colophon âš¡